Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
Want to compare other data? Select Fields| Symbol | DNLI | ARNA | BHVN | ||
| Company | Denali Therapeutics Inc | Arena Pharmaceuticals | Biohaven Pharmaceutical Holding Company Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 25.02 | 53.81 | 45.91 | ||
| High | 25.02 | 54.87 | 46.71 | ||
| Low | 25.02 | 53.26 | 45.20 | ||
| Last | 25.02 | 54.00 | 45.33 | ||
| Change | -0.40 | +0.18 | -0.30 | ||
| % Change | -1.57% | +0.33% | -0.66% | ||
| Volume | 250 | 420,700 | 459,300 | ||
| 20-Day Average Volume | 876,763 | 561,060 | 1,377,275 | ||
| Previous Close | 25.42 | 53.82 | 45.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.48 | 48.16 | 51.33 | ||
| 20-Day Raw Stochastic | 42.29% | 91.66% | 6.41% | ||
| 20-Day Relative Strength | 58.63% | 70.94% | 39.46% | ||
| Weighted Alpha | +31.78 | +11.40 | +11.80 | ||
| Today's Opinion | 88% Buy | 24% Buy | 8% Sell | ||
| Previous Opinion | 88% Buy | 24% Buy | 8% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.85% since 02/10/20 | +5.26% since 02/07/20 | -11.55% since 02/07/20 | ||
| Low | 23.78 on 02/11/20 | 47.50 on 02/13/20 | 44.35 on 02/13/20 | ||
| High | 26.35 on 02/14/20 | 55.00 on 02/13/20 | 49.26 on 02/10/20 | ||
| 1-Month | |||||
| %Chg | +11.90% since 01/17/20 | +18.24% since 01/14/20 | -12.84% since 01/14/20 | ||
| Low | 21.07 on 01/21/20 | 43.01 on 01/27/20 | 44.35 on 02/13/20 | ||
| High | 30.41 on 01/27/20 | 55.00 on 02/13/20 | 59.65 on 01/22/20 | ||
| 3-Month | |||||
| %Chg | +64.07% since 11/18/19 | +18.88% since 11/14/19 | -7.53% since 11/14/19 | ||
| Low | 15.07 on 11/19/19 | 43.01 on 01/27/20 | 44.35 on 02/13/20 | ||
| High | 30.41 on 01/27/20 | 55.00 on 02/13/20 | 59.65 on 01/22/20 | ||
| 6-Month | |||||
| %Chg | +37.78% since 08/16/19 | +0.65% since 08/14/19 | +19.26% since 08/14/19 | ||
| Low | 14.24 on 10/18/19 | 43.01 on 01/27/20 | 36.69 on 08/27/19 | ||
| High | 30.41 on 01/27/20 | 58.56 on 08/19/19 | 59.65 on 01/22/20 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,441,108 | 2,705,778 | 2,368,039 | ||
| Shares Outstanding, K | 96,031 | 50,107 | 52,240 | ||
| Annual Sales | 129,160,000 | 17,970,000 | 0 | ||
| Annual Net Income | -36,240,000 | -29,400,000 | -240,920,000 | ||
| Last Quarter Sales | 13,600,000 | 1,350,000 | N/A | ||
| Last Quarter Net Income | -46,260,000 | -72,870,000 | N/A | ||
| 60-Month Beta | 2.05 | 1.64 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.46 on 11/07/19 | -2.04 on 11/01/19 | ||
| Latest Earnings Date | 03/10/20 | 02/25/20 | 02/27/20 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.27 | 0.00 | ||
